BioSpace News Archive

Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”) today announced that the Company will participate in the Piper Sandler 35th Annual Healthcare Conference, which takes place November 28 – 30, 2023 in New York.

Tenaya Therapeutics, Inc. (NASDAQ: TNYA) today announced that Faraz Ali, Chief Executive Officer, will participate in the 35th Annual Piper Sandler Healthcare Conference taking place in New York, NY.

Kane Biotech Inc. will announce its third quarter 2023 financial results after market close on Tuesday, November 28, 2023.

Touchlight announced that the Company has used its proprietary dbDNA as a critical starting material for manufacturing of VMB-100, a potency enhanced messenger ribonucleic acid encoding human insulin-like growth factor-1 to support Versameb’s first-in-human clinical study to treat chronic stress urinary incontinence.

ZYUS Life Sciences Corporation is pleased to announce receipt of the final clinical study report and positive results respecting its Phase 1, first-in-human (“FIH”) Clinical Trial for its lead drug product candidate, Trichomylin® softgels.

Jnana Therapeutics today announced that Joanne Kotz, Ph.D., Co-founder and Chief Executive Officer, will present a corporate overview at the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023 at 9:50 a.m. ET.

ESSA Pharma Inc. today announced that the Company will be presenting at the Piper Sandler 35th Annual Healthcare Conference on Thursday, November 30, 2023, at 12:00 p.m. ET in New York.

Viridian Therapeutics, Inc. today announced that senior management will participate in a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference on Thursday, November 30 at 11:15am ET in Miami, Florida.

Astria Therapeutics, Inc. today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will present a corporate overview and information on STAR-0215 and STAR-0310 at the 6th Annual Evercore ISI HealthCONx Conference on Thursday November 30, at 8:45am ET in Miami, FL.

Cyclo Therapeutics, Inc. today announced its abstract has been accepted for platform presentation at the 20th Annual WORLDSymposium™ being held February 4-9, 2024 in San Diego, CA.